Date | Title | Description | |
---|---|---|---|
16 Feb 2023 | On business and financial situation | The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. | Download |
09 Jan 2023 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the fourth quarter of 2022 | Download |
15 Dec 2022 | On Corporate Governance | The Company informs about changes in the Board of Directors and the creation of an Advisory Committee. | Download |
04 Oct 2022 | On business and financial situation | The Company informs that it has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value. | Download |
03 Oct 2022 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the third quarter of 2022 | Download |
Pages
Date | Title | Description | |
---|---|---|---|
03 Jul 2012 | Información sobre dividendos | Download | |
13 Jun 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
26 Apr 2012 | Información sobre resultados (2) | Download | |
26 Apr 2012 | Información sobre resultados | Download | |
26 Apr 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download |